Upstream Bio Appoints Rand Sutherland As CEO, Mike Gray As CFO and COO, and Lisa Fiering As Svp, People & Culture

Apr 02, 2024•over 1 year ago

Position

Chief Executive Officer

Company

Upstream Bio

Rand Sutherland

WalthamBiotechnologyScience And EngineeringHealth Care

Description

Upstream Bio, a clinical-stage biotech company, announced strategic leadership changes including the appointment of Rand Sutherland, MD, as Chief Executive Officer. The company also appointed Mike Gray as Chief Financial Officer and Chief Operating Officer, and Lisa Fiering as Senior Vice President of People & Culture. These leadership changes aim to support the growth and evolution of Upstream as the company works to advance verekitug for respiratory disorders.

Company Information

Company

Upstream Bio

Location

Waltham, Massachusetts, United States

About

At Upstream Bio we strive to reach the source of inflammation and conquer it. Our lead program is a clinical-stage monoclonal antibody that inhibits the TSLP receptor. TSLP is a validated target positioned upstream of multiple signaling cascades that affect a variety of immune cells pivotal to common and rare diseases. We are leveraging our diverse roots and the team’s substantial industry experience to develop therapies that ease the burden of inflammatory and allergic diseases on patients and their loved ones.

Related People

Executive Insights

Based on hiring data

New executive impact window

87% of new executives make significant technology decisions within first 100 days

Budget influence

C-level executives control 73% of technology spending decisions

Transformation catalyst

65% of new senior hires launch digital transformation initiatives

Vendor review timeline

New executives typically review existing vendors within 6 months